The role of the sialic acid in monitoring the evolution of malignant melanoma. From murine models to human research

1. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007 Jan;12(1):20-37.10.1634/theoncologist.12-1-20Search in Google Scholar

2. DeVita V, Lawrence T, Rosenberg S. Principles & Practice of oncology, 9th edition. 2011;119:1660-76.Search in Google Scholar

3. Ross MI, Stern SJ. Mucosal Melanomas. St. Louis Quality Medical Publishing Inc. 1998;3:195-208.Search in Google Scholar

4. Chang P, Knapper WH. Metastatic Melanoma of Unknown Primary. Cancer. 2006;49(6):1106-11.10.1002/1097-0142(19820315)49:6<1106::AID-CNCR2820490607>3.0.CO;2-0Search in Google Scholar

5. Murali R, Shaw HM, Lai K, et al. Prognostic Factors in Cutaneous Desmoplastic Melanoma: A Study of 252 Patients. Cancer. 2010;116(17):4130.10.1002/cncr.25148Search in Google Scholar

6. Schrohl AS, Anderson MH, Sweep F, Schmitt M, Harbeck N, Foekens J, et al. Tumor Markers: From Laboratory to Clinical Utility. Mol Cell Proteomics. 2003 Jun;2:378-87.10.1074/mcp.R300006-MCP200Search in Google Scholar

7. Wu JT. Diagnosis and Management of Cancer Using Serological Tumor Markers. Henry′s Clinical Diagnosis and Management by Laboratory Methods. 2007; 21: 47-52.Search in Google Scholar

8. Gershou YL, Stanley H, Jules H, John MJ. ASCO 2006 Update of Recomandations for the Use of Tumor Markers in Colon Cancer. Jurnal of Clinical Oncology. 2006 Jun;6:23-26.Search in Google Scholar

9. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting Recommendations for Tumor Marker Prognostic Studies. Journal of Clinical Oncology. 2005;23(36): 9067-72.10.1200/JCO.2004.01.0454Search in Google Scholar

10. Clinical Practice Guidelines for the Use of Tumor Markers in Breast and Colorectal Cancer. Adopted on May 17, 1996, by the American Society of Clinical Oncology. Journal of Clinical Oncology. 1996;14:2843-77.10.1200/JCO.1996.14.10.2843Search in Google Scholar

11. International Germ Cell Consensus Classification: A Prognostic Factor-based Staging System for Metastatic Germ Cell Cancers. International Germ Cell Cancer Collaborative Group. Journal of Clinical Oncology. 1997;15:594-603.10.1200/JCO.1997.15.2.594Search in Google Scholar

12. Eriksson B, Oberg K, Stridsberg M. Tumor Markers in Neuroendocrine Tumors. Digestion International Journal of Gastroenterology. 2000;62:33-38.10.1159/000051853Search in Google Scholar

13. Sturgeon C. Practice Guidelines for Tumor Marker Use in Clinic. Clin Chem. 2002;48:1151-59.10.1093/clinchem/48.8.1151Search in Google Scholar

14. Locker GY, Hamilton S, Harris J. ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer. Journal of Clinical Oncology. 2006;24:5313-27.10.1200/JCO.2006.08.2644Search in Google Scholar

15. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer. V.3.2011. Accessed at www.nccn.org on March 14, 2011.Search in Google Scholar

16. Gajeroski TF, Grimm EA, Nickoloff BJ. New Potential Therapeutic Targets in Melanoma. ASCO Annual Meeting. 2008;123-125.Search in Google Scholar

17. Narayanan S. Sialic Acid as a Tumor Marker. Ann Clin Lab Sci. 1994 Jul-Aug;24(4):376-84.Search in Google Scholar

18. Dube HD, Bertozzi RC. Glycans in Cancer and Inflamation -potential for therapeutics and diagnostics. Nature Reviews Drug Discovery. 2005 June;4:477-448.10.1038/nrd1751Search in Google Scholar

19. Feijoo C, Paez de la Cadena M, Rodriguez-Berrocal FJ, Martinez-Zorzano VS. Sialic Acid Levels in Serum and Tissue from Colorectal Cancer Patients. Cancer Lett. 1997;112:155-160.10.1016/S0304-3835(96)04564-8Search in Google Scholar

20. Redondo-Garcia P, Nakamura CV, Souza W, Morgado- Diaz JA. Differential Expression of Sialic Acid and N-acetyl-galactosamine Residues on the Cell Surface of Intestinal Epithelial Cells According to Normal or Metastatic Potential. J Histochem Cytochem. 2004 May;52:629-40.10.1177/002215540405200507Search in Google Scholar

21. Holzmann B, Brocker E, Lehmann MJ, Ruiter DJ, Sorg C, Riethmuller G. Tumor Progression in Human Malignant Melanoma: Five Stages Defined by Their Antigenic Phenotypes. International Journal of Cancer. 1987 April;39:466-71.10.1002/ijc.2910390410Search in Google Scholar

22. Silver HK, Rangel DM, Morton DL. Serum Sialic Acid Elevations in Malignant Melanoma Patients. Cancer. 1978;41(4):1497-99.10.1002/1097-0142(197804)41:4<1497::AID-CNCR2820410438>3.0.CO;2-9Search in Google Scholar

23. Taylor G. Sialidases: Structures, Biological Significance and Therapeutic Potential. Curr Opin Struct Biol. 1996;6:830-37.10.1016/S0959-440X(96)80014-5Search in Google Scholar

24. Watkins E, Anderson I, Nebril LR, Waters IF, Connery CK. Neuraminidase-mediated Augmentation of in Vitro Immune Response of Patients with Solid Tumors. Int. J. Cancer. 2007;14:799-805.Search in Google Scholar

25. Ros-Bullon MR, Sanchez-Pedreno P, Martinez-Liarte JH. Serum Sialic Acid in Malignant Melanoma Patients: an ROC Curve Analysis. Anticancer Res. 1999 Jul- Aug;19(4C):3619-22.Search in Google Scholar

26. Miyata M, Kambe M, Tajima O, Moriya S, Kondo Y, Narimatsu H, et al. Membrane sialidase NEU3 is Highly Expressed in Human Melanoma Cells Promoting Cell Growth with Minimal Changes in the Composition of Gangliosides. Cancer Science. 2011 Dec;102:2139-49.10.1111/j.1349-7006.2011.02086.xSearch in Google Scholar

27. Miyagi T, Wada T, Yamaguchi K. Roles of Plasma Membrane-associated Sialidase NEU3 in Human Cancers. Biochim Biophys Acta. 2008;(7):532-78.10.1016/j.bbagen.2007.09.016Search in Google Scholar

28. Suzuki Y, Ito T, Suzuki T. Sialic Acid Species as a Determinant of the Host Range of Influenza A Viruses. J Virol. 2000;74:11825-831.10.1128/JVI.74.24.11825-11831.2000Search in Google Scholar

29. Lehmann F, Tiralongo E, Tiralongo J. Sialic Acid - Specific Lectins: Occurrence, Specificity and Function. Cell Mol Life Sci. 2006;63:1331-54.10.1007/s00018-005-5589-ySearch in Google Scholar

30. Katterman R, Kriege R. Chem. Biochem. 1981;19(1):31-4.Search in Google Scholar

31. Kinoshita Y, Sato S, Takeuchi T. Cellular Sialic Acid Level and Phenotypic Expression in B16 Melanoma Cells: Comparison of Spontaneous Variations and Bromodeoxyuridine- and Theophylline-Induced Changes. Cell Structure and Function. 1989;14:35-43.10.1247/csf.14.352720797Search in Google Scholar

32. Korangath Preethi C, Kodappully Siveen S, Kuttan R, Kuttan G. Inhibition of Metastasis of B16-F10 Melanoma Cells in C57BL/6 Mice by an Extract of Calendula Officinalis L Flowers. Asian Pacific Journal of Cancer Prevention. 2010;11:1773-79.Search in Google Scholar

33. Schauer R. Sialic Acids as Regulators of Molecular and Cellular Interactions. Curr Opin Struct Biol. 2009;19:507-514.10.1016/j.sbi.2009.06.003712737619699080Search in Google Scholar

34. Lloyd KO, Furukawa K. Biosynthesis and Functions of Gangliosides: Recent Advances. Glycoconj J. 1998;15:627-36.10.1023/A:1006924128550Search in Google Scholar

35. Wada T, Hata K, Yamaguchi K. A Crucial Role of Plasma Membrane-associated Sialidase in the Survival of Human Cancer Cells. Oncogene. 2007;26:2483-90.10.1038/sj.onc.121034117334392Search in Google Scholar

36. Monti E, Bassi MT, Papini N. Identification and Expression of NEU 3, a Novel Human Sialidase- associated to the plasma membrane. Biochem J. 2000;349:343-51.10.1042/bj3490343Search in Google Scholar

37. Kannagi R. Carbohydrate Antigen Sialyl Lewis Pathophysiological Significance and Induction Mechanism in Cancer Progression. Chang Gung Med J. 2007;30:189-209.Search in Google Scholar

38. Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim. Biophys. Acta. 2008 Apr;1785(2):182-206.10.1016/j.bbcan.2007.11.00218166162Search in Google Scholar

39. Schauer R. Achievements and Challenges of Sialic Acid Research. Glycoconj J. 2000;17:485-99.10.1023/A:1011062223612Search in Google Scholar

40. Bardor M, Nguyen DH, Diaz S, Varki A. Mechanism of Uptake and Incorporation of the non-human Sialic Acid N-glycolylneuraminic acid into human cells. J Biol Chem. 2005;280:4228-37.10.1074/jbc.M41204020015557321Search in Google Scholar

41. Hedlund M, Tangvoranuntakul P, Takematsu H, Long JM, Housley GD, Kozutsumi Y, et al. N-glycolylneuraminic Acid Deficiency in Mice: Implications for hu- man biology and evolution. Moll Cell Biol. 2007;27:4340-46.10.1128/MCB.00379-07190003517420276Search in Google Scholar

42. Varki A. Glycan-based Interactions Involoving Vertebrate Sialic Acid Recognizing Proteins. Nature. 2007; 446:1023-9.10.1038/nature0581617460663Search in Google Scholar

43. Gabri R, Otero L, Gomez D, Alonso D. Exogenous Incorporation of Neugc-rich Mucin Augments n-glycolyl Sialic Acid Content and Promotes Malignant Phenotype in Mouse Tumor Cell Lines. Journal of Experimental and Clinical Cancer Research. 2009;28:146-158.10.1186/1756-9966-28-146279575019951433Search in Google Scholar

44. Ohyama C. Glycosylation in Bladder Cancer. Int. J. Clin. Oncol. 2008;13:308-13.10.1007/s10147-008-0809-818704630Search in Google Scholar

45. Yin J, Hashimoto A, Izawa M, Miyazaki K, Chen GY, Tkematsu H, et al. Hipoxic Cultures Induces Expression of Sialin, a Sialic Acid Transporter and Cancer Associated gangliosides containing non-human sialic acid on Human Cancer Cells. Cancer Res. 2006;66:2937-45.10.1158/0008-5472.CAN-05-261516540641Search in Google Scholar

46. Engers R, Gabbert HE. Mechanism of Tumor Metastasis: Cell Biological Aspects and Clinical Implications. J. Cancer Res Clin Oncol. 2000;126:682-92.10.1007/s00432000014811153140Search in Google Scholar